Differential expression profiling of genes in a complete hydatidiform mole using cDNA microarray analysis

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 654-660

  Kim, Seung Jo ^a   Lee, Sun Young ^a   Lee, Chan ^a   Kim, Inho ^a   An, Hee Jung ^a   Kim, Ji Young ^a   Baek, Kwang Hyun ^b   Kim, Eun Joong ^b   Kim, Jung Mogg ^c   Lee, Jung Bok ^d   Lee, Jae Won ^d   Jung, Woon Won ^e   Chun, Taehoon ^d   Oh, Yu Kyoung ^d  

^a CHA General Hospital   (South Korea)

^b CHA University   (South Korea)

^c Hanyang University   (South Korea)

^d Korea University   (South Korea)

^e My Gene Bioscience Institute   (South Korea)

Author keywords

cDNA microarray; Complete hydatidiform mole; Expression profiling

Indexed keywords

COMPLEMENTARY DNA;

APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; COMPARATIVE STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TRANSCRIPTION REGULATION; UPREGULATION;

DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; HYDATIDIFORM MOLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY;

EID: 33750987910     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.015     Document Type: Article

References (34)

1. Altieri A., Franceschi S., Ferlay J., Smith J., and La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4 (2003) 670-678
2. Smith H.O., Kohorn E., and Cole L.A. Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin North Am 32 (2005) 661-684
3. Fisher R.A., Nucci M.R., Thaker H.M., Weremowicz S., Genest D.R., and Castrillon D.H. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 17 (2004) 1155-1160
4. Briese J., Oberndorfer M., Schulte H.M., Loning T., and Bamberger A.M. Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1. Int J Gynecol Pathol 24 (2005) 271-276
5. Kim S.J., Park S.E., Lee C., Lee S.Y., Kim I.H., An H.J., et al. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Gynecol Oncol 88 (2003) 411-418
6. Fong P.Y., Xue W.C., Ngan H.Y., Chiu P.M., Chan K.Y., Tsao S.W., et al. Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study. J Clin Pathol 59 (2006) 179-183
7. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30 (2002) e15
8. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
9. Dobbin K., Shih J.H., and Simon R. Statistical design of reverse dye microarrays. Bioinformatics 19 (2003) 803-810
10. Slater E.P., Diehl S.M., Langer P., Samans B., Ramaswamy A., Zielke A., et al. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol 154 (2006) 587-598
11. Thompson K.L., Rosenzweig B.A., Pine P.S., Retief J., Turpaz Y., Afshari C.A., et al. Use of a mixed tissue RNA design for performance assessments on multiple microarray formats. Nucleic Acids Res 33 (2005) e187
12. Rochard P., Galiegue S., Tinel N., Peleraux A., Bord A., Jbilo O., et al. Expression of the peripheral benzodiazepine receptor triggers thymocyte differentiation. Gene Expr 12 (2004) 13-27
13. Berger J.A., Hautaniemi S., Jarvinen A.K., Edgren H., Mitra S.K., and Astola J. Optimized LOWESS normalization parameter selection for DNA microarray data. BMC Bioinformatics 5 (2004) 194
14. Listgarten J., Graham K., Damaraju S., Cass C., Mackey J., and Zanke B. Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides. Appl Bioinformatics 2 (2003) 219-228
15. Sieben N.L., Oosting J., Flanagan A.M., Prat J., Roemen G.M., Kolkman-Uljee S.M., et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J Clin Oncol 23 (2005) 7257-7264
16. Chandran U.R., Dhir R., Ma C., Michalopoulos G., Becich M., and Gilbertson J. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 13 5 (2005) 45
17. Baer C., Nees M., Breit S., Selle B., Kulozik A.E., Schaefer K.L., et al. Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma. Int J Cancer 110 10 (2004) 687-694
18. Schramm A., Schulte J.H., Klein-Hitpass L., Havers W., Sieverts H., Berwanger B., et al. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene 24 24 (2005) 7902-7912
19. Chun J.H., Kim H.K., Kim E., Kim I.H., Kim J.H., Chang H.J., et al. Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer. Cancer Res 64 (2004) 4703-4706
20. Kato H.D., Terao Y., Ogawa M., Matsuda T., Arima T., Kato K., et al. Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol 21 (2002) 255-260
21. Feng H.C., Tsao S.W., Ngan H.Y., Xue W.C., Chiu P.M., and Cheung A.N. Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study. Cancer 104 (2005) 2409-2416
22. Trisal V., Zhou M., Shen B., and Chu D. Over expression of Capping protein Z line alpha 1(CAPZA 1) and protein phosphatase 1 (PP 1) in malignant melanoma as identified by subtractive hybridization. J Clin Oncol 22 14S (2004) 7518
23. Jones J.M., Datta P., Srinivasula S.M., Ji W., Gupta S., Zhang Z., et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425 (2003) 721-727
24. Lee S.H., Lee J.W., Kim H.S., Kim S.Y., Park W.S., Kim S.H., et al. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS 111 5 (2003) 586-590
25. Jenkins Y., Markovtsov V., Lang W., Sharma P., Pearsall D., Warner J., et al. Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell 16 (2005) 5621-5629
26. Ovaa H., Kessler B.M., Rolen U., Galardy P.J., Ploegh H.L., and Masucci M.G. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc Natl Acad U S A 101 (2004) 2253-2258
27. Pollheimer J., Loregger T., Sonderegger S., Saleh L., Bauer S., Bilban M., et al. Activation of the canonical wingless/t-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 168 (2006) 1134-1147
28. Su F., Overholtzer M., Besser D., and Levine A.J. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev 16 (2002) 46-57
29. Sathyanarayana U.G., Padar A., Huang C.X., Suzuki M., Shigematsu H., Bekele B.N., et al. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Clin Cancer Res 9 (2003) 6389-6394
30. Sathyanarayana U.G., Maruyama R., Padar A., Suzuki M., Bondaruk J., Sagalowsky A., et al. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 64 (2004) 1425-1430
31. Sathyanarayana U.G., Padar A., Suzuki M., Maruyama R., Shigematsu H., Hsieh J.T., et al. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 9 (2003) 6395-6400
32. Ema H., Sudo K., Seita J., Matsubara A., Morita Y., Osawa M., et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell 8 (2005) 907-914
33. Tong W., and Lodish H.F. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 200 (2004) 569-580
34. Klampfer L., Huang J., Corner G., Mariadason J., Arango D., Sasazuki T., et al. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. J Biol Chem 278 (2003) 46278-46287